Janux Therapeutics, Inc. (JANX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.58
Day's range
$14.29

Janux Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 11.19 M $171.87 M   0.00% 17.78%
BLACKROCK, INC. 08/07/2026 6.13 M $94.23 M   12.91% 9.75%
PROSIGHT MANAGEMENT, LP 08/14/2026 3.80 M $58.44 M   7.17% 6.04%
STATE STREET CORP 08/07/2026 3.00 M $46.16 M   21.95% 4.77%
FMR LLC 08/13/2026 2.41 M $37.06 M   -4.85% 3.83%
FEDERATED HERMES, INC. 08/12/2026 2.35 M $36.14 M   4,241.19% 3.74%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 1.99 M $30.63 M   72.46% 3.17%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.86 M $28.53 M   2.54% 2.95%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 1.79 M $27.49 M   0.00% 2.84%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 1.65 M $25.30 M   2.88% 2.62%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 1.51 M $23.15 M   -5.65% 2.40%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 1.33 M $20.44 M   3.14% 2.11%
TWO SIGMA INVESTMENTS, LP 08/14/2026 1.21 M $18.54 M   939.85% 1.92%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.20 M $18.50 M   5.01% 1.91%
CITADEL ADVISORS LLC 09/02/2026 1.20 M $18.44 M   240.95% 1.91%
ALGERT GLOBAL LLC 08/13/2026 1.11 M $17.06 M   150.54% 1.77%
D. E. SHAW & CO., INC. 08/14/2026 1.10 M $16.84 M   1,014.40% 1.74%
GOLDMAN SACHS GROUP INC 08/14/2026 952.68 K $14.63 M   58.25% 1.51%
BANK OF AMERICA CORP /DE/ 08/14/2026 910.46 K $13.98 M   13.57% 1.45%
MORGAN STANLEY 08/13/2026 836.97 K $12.86 M   18.90% 1.33%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 809.91 K $12.44 M   0.00% 1.29%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 702.06 K $10.78 M   256.11% 1.12%
SQUAREPOINT OPS LLC 08/14/2026 532.32 K $8.18 M   -11.87% 0.85%
ORBIMED ADVISORS LLC 08/14/2026 524.70 K $8.06 M   -46.66% 0.83%
MILLENNIUM MANAGEMENT LLC 08/14/2026 504.54 K $7.75 M   30.44% 0.80%
HRT FINANCIAL LP 08/14/2026 491.00 K $7.54 M   33.90% 0.78%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 420.88 K $6.46 M   40.98% 0.67%
NORTHERN TRUST CORP 08/13/2026 398.37 K $6.12 M   9.99% 0.63%
JANE STREET GROUP, LLC 08/14/2026 391.99 K $6.02 M   55.71% 0.62%
NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. 08/07/2026 376.50 K $5.78 M   0.00% 0.60%
WOODLINE PARTNERS LP 08/14/2026 370.03 K $5.68 M   -49.86% 0.59%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 369.19 K $5.67 M   4.19% 0.59%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 369.19 K $5.67 M   100.00% 0.59%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 367.01 K $5.64 M   0.00% 0.58%
JUMP FINANCIAL, LLC 08/13/2026 361.67 K $5.56 M   63.06% 0.57%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 359.73 K $5.53 M   272.27% 0.57%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 315.27 K $4.84 M   0.52% 0.50%
PANAGORA ASSET MANAGEMENT INC 08/06/2026 269.11 K $4.13 M   100.00% 0.43%
MAN GROUP PLC 08/14/2026 248.80 K $3.82 M   -27.46% 0.40%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 211.64 K $3.25 M   -80.59% 0.34%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 209.59 K $3.22 M   99.04% 0.33%
Y-INTERCEPT (HONG KONG) LTD 07/14/2026 196.49 K $3.02 M   40.38% 0.31%
JPMORGAN CHASE & CO 08/12/2026 178.54 K $2.74 M   -22.13% 0.28%
JUPITER TOPCO LLC 08/14/2026 172.23 K $2.65 M   100.00% 0.27%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 08/13/2026 166.09 K $2.43 M   -1.71% 0.26%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 156.50 K $2.40 M   -56.83% 0.25%
BML CAPITAL MANAGEMENT, LLC 08/07/2026 154.96 K $2.38 M   0.00% 0.25%
UBS GROUP AG 08/13/2026 150.70 K $2.31 M   -31.44% 0.24%
BANK OF NEW YORK MELLON CORP 08/06/2026 135.07 K $2.07 M   12.72% 0.21%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 133.87 K $2.06 M   12.14% 0.21%

Janux Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 251 institutional investors and hedge funds held shares of Janux Therapeutics Inc. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 11.19 M

BlackRock, Inc.: 6.13 M

Prosight Management, LP: 3.8 M

STATE STREET CORP: 3 M

FMR LLC: 2.41 M

FEDERATED HERMES, INC.: 2.35 M

97.17% of Janux Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 71.70 M shares in the last 24 months. This purchase volume represents approximately $1.00 B in transactions.